Sana Biotechnology Inc (SANA)
8.715
+0.16
(+1.93%)
USD |
NASDAQ |
May 17, 16:00
8.715
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Stock Buybacks (Quarterly): -181.47M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -181.47M |
| December 31, 2023 | -1.718M |
| September 30, 2023 | -0.187M |
| June 30, 2023 | -29.74M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -1.061M |
| September 30, 2022 | -1.621M |
| June 30, 2022 | -1.579M |
| March 31, 2022 | -0.652M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.346M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -626.40M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-626.40M
Minimum
Mar 2021
--
Maximum
Mar 2020
-49.99M
Average
-0.652M
Median
Mar 2022
Stock Buybacks (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | -1.184M |
| Solid Biosciences Inc | -111.92M |
| Dyne Therapeutics Inc | -397.47M |
| Taysha Gene Therapies Inc | -- |
| Tenaya Therapeutics Inc | -46.76M |